Abraham Meizler
Amministratore Delegato presso Advantech Bioscience Pharmaceutical Ltd.
Profilo
Abraham Meizler is the founder of Atme Comercio E Serviços Ltda.
(founded in 2002), Meizler Biopharma SA (founded in 1990), and Advantech Bioscience Pharmaceutical Ltd.
(founded in 2010).
At Meizler Biopharma SA, he held the title of President from 1990 to 2012.
At Advantech Bioscience Pharmaceutical Ltd., he currently holds the title of Chief Executive Officer.
Mr. Meizler's former jobs include Chairman of SciSparc Ltd.
(2013-2014), Chairman & Vice President-Business Development of Meizler UCB Biopharma SA (2012-2014), Director of Kadimastem Ltd.
(2014-2020), and Director of Raziel Therapeutics RT Ltd.
Mr. Meizler earned an MBA from Getulio Vargas Foundation.
Posizioni attive di Abraham Meizler
| Società | Posizione | Inizio |
|---|---|---|
| Advantech Bioscience Pharmaceutical Ltd. | Amministratore Delegato | 01/01/2010 |
Precedenti posizioni note di Abraham Meizler
| Società | Posizione | Fine |
|---|---|---|
| KADIMASTEM LTD | Direttore/Membro del Consiglio | 17/12/2020 |
| Meizler UCB Biopharma SA | Presidente | 01/12/2014 |
Meizler Biopharma SA
 Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Fondatore | 01/01/2012 |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Direttore/Membro del Consiglio | - |
Atme Comercio E Serviços Ltda.
 Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Fondatore | - |
Formazione di Abraham Meizler
| Getulio Vargas Foundation | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SCISPARC LTD. | Health Technology |
| KADIMASTEM LTD | Health Technology |
| Aziende private | 5 |
|---|---|
| Meizler UCB Biopharma SA | |
Meizler Biopharma SA
Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Health Technology |
| Advantech Bioscience Pharmaceutical Ltd. | |
Atme Comercio E Serviços Ltda.
Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Finance |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
- Borsa valori
- Insiders
- Abraham Meizler
